Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1.

by Jonathan T Sims, Sourik S Ganguly, Holly Bennett, J Woodrow Friend, Jessica Tepe, Rina Plattner
Published 2013-01-01

KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung Cancer

by Kristen S. Hill, Anthony McDowell, J. Robert McCorkle, Erin Schuler, Sally R. Ellingson, Rina Plattner, Jill M. Kolesar
Published 2021-04-01

Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling

by Rakshamani Tripathi, Zulong Liu, Aditi Jain, Anastasia Lyon, Christina Meeks, Dana Richards, Jinpeng Liu, Daheng He, Chi Wang, Marika Nespi, Andrey Rymar, Peng Wang, Melissa Wilson, Rina Plattner
Published 2020-10-01

Enhanced Resistance to Tamoxifen by the c-ABL Proto-oncogene in Breast Cancer

by Huajun Zhao, Fu Ou-Yang, I-Fen Chen, Ming-Feng Hou, Shyng-Shiou F. Yuan, Hsueh-Ling Chang, Yi-Chen Lee, Rina Plattner, Susan E. Waltz, Shuk-Mei Ho, Jonathan Sims, Shao-Chun Wang
Published 2010-03-01